Johnson & Johnson

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Commitment removed

SBTI ID

40007032

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

04/04/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Johnson & Johnson commits to reduce absolute scope 1 and 2 GHG emissions 44% by 2030 from a 2021 base year.* Johnson & Johnson also commits that 80% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution, will have science-based targets by 2028. * The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.

Net-Zero

Statut

Commitment removed
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

27/05/2021

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

US4781601046

LEI

549300G0CFPGEF6X2043

Note

Expired commitment

Source : Science Based Targets initiative | Données publiques